13F

Stock

Tarsus Pharmaceuticals, Inc.

TARS · held by 4 managers

Reported value

$23M

Holders

4

+0 new · −0 exited

Holders’ est. mark

−$229K

Price effect on 3 books still in the name

Largest holder

$20.1M

NORGES BANK

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
NORGES BANK391.1K$20.1MHeld
BARCLAYS PLC52.8K$2.71M−$211.4KCut−$1.42M
Marex Group plc4.4K$226K−$17.6KCut−$17.6K
Catherine Avery Investment Management LLC13$668−$52Cut−$439

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.